Mangoceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-1.3M | $-1.4M | $43.1K | $234.1K |
| FY2023 | $-7.0M | $-7.0M | $3.5K | $624.5K |
| FY2024 | $-4.9M | $-4.9M | — | $248.7K |
| FY2025 | $-5.9M | $-5.9M | — | $1.2M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-1.3M | $-1.4M | $43.1K | $234.1K |
| FY2023 | $-7.0M | $-7.0M | $3.5K | $624.5K |
| FY2024 | $-4.9M | $-4.9M | — | $248.7K |
| FY2025 | $-5.9M | $-5.9M | — | $1.2M |